Acquisition History NBN Infusions was acquired by PromptCare in early 2021 and subsequently sold to Prompt Care in 2023, indicating a history of M&A activity and evolving ownership. This suggests potential for partnerships with successor entities or portfolio companies seeking integrated home infusion and respiratory services.

Market Focus Specializes in home infusion and respiratory therapy for a broad range of conditions including COPD, asthma, sleep apnea, and lung diseases. This focus aligns with opportunities to cross-sell home infusion solutions to larger hospital systems and primary care networks expanding outpatient and at-home care.

Financial Signals Current revenue range is modest (1M–10M) with a lean employee base, indicating a smaller, potentially agile target for upsell of scalable infusion programs, managed services, or technology-enabled home care solutions to drive margins and growth.

Tech Footprint Utilizes common cloud and web technologies (Cloudflare, Google Analytics, Nginx/OpenResty) suggesting a modern but possibly resource-constrained IT footprint. Opportunity exists to offer clinical data integration, telehealth enablement, and analytics-enabled care coordination platforms.

Competitive Positioning Operating in a space with large players and healthcare providers (similarities to Optum/ CVS Caremark scale). Positioning opportunities include partnering with payer networks or hospital systems to provide specialized home infusion and respiratory services as part of value-based care programs.